It has been said that the control of disease has three goals, which, in increasing order of attraction are palliation, cure, and prevention. For most types of disseminated cancer, medical science has achieved only the first of these objectives, while for some malignancies the side effects of the therapeutic agents employed rival the disease itself in precluding a desirable quality of life. In contrast, those cancers of the breast and prostate that retain the hormone dependency of the tissue of origin, and thus are sensitive to endocrine manipulation, offer a more favorable situation for control. Hormone Therapy in Breast and Prostate Cancer takes the reader on a fascinating.
